Analyst · Avalyn Pharma Inc. Common Stock (AVLN) | Ratings, Price Targets & Consensus

Analyst Consensus

Analyst recommendation mix is not available yet.

Total Analysts4

Ratings

Updated Jul 27, 2026

Overall Rating

C

DCF Score3.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score3.0 / 5

Valuation

Current Stock Price

$27.95

Median Target+111.09%

$59.00

Potential upside vs current price

DCF Value-95.93%

$1.14

Potential downside vs current price